OMGAOmega Therapeutics, Inc.

Nasdaq omegatherapeutics.com


$ 2.31 $ 0.01 (0.43 %)    

Monday, 29-Apr-2024 10:18:05 EDT
QQQ $ 432.16 $ -0.99 (-0.23 %)
DIA $ 383.40 $ 0.21 (0.05 %)
SPY $ 510.04 $ -0.22 (-0.04 %)
TLT $ 88.74 $ 0.08 (0.09 %)
GLD $ 216.10 $ 0.05 (0.02 %)
$ 2.27
$ 2.30
$ 0.00 x 0
$ 2.27 x 400
$ 2.30 - $ 2.31
$ 1.30 - $ 10.09
257,466
na
122.6M
$ 1.68
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-28-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-03-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 03-01-2023 12-31-2022 10-K
6 11-08-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-04-2022 03-31-2022 10-Q
9 03-10-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 09-10-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 omega-therapeutics-presents-new-preclinical-data-supporting-the-potential-of-precision-epigenomic-control-at-aacr-2024

MYC-directed epigenomic controller exerts anti-tumor effect in preclinical models of EGFR inhibitor-resistant NSCLC regardles...

 piper-sandler-reiterates-overweight-on-omega-therapeutics-lowers-price-target-to-9

Piper Sandler analyst Edward Tenthoff reiterates Omega Therapeutics (NASDAQ:OMGA) with a Overweight and lowers the price tar...

 chardan-capital-maintains-buy-on-omega-therapeutics-lowers-price-target-to-7

Chardan Capital analyst Keay Nakae maintains Omega Therapeutics (NASDAQ:OMGA) with a Buy and lowers the price target from $1...

 omega-therapeutics-q4-2023-gaap-eps-037-beats-047-estimate

Omega Therapeutics (NASDAQ:OMGA) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(...

 why-applied-therapeutics-shares-are-trading-lower-by-over-35-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Applied Therapeutics, Inc.

 crude-oil-moves-lower-walgreens-posts-upbeat-earnings

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining over 100 points on Thursday. The Dow trad...

 wedbush-reiterates-outperform-on-omega-therapeutics-maintains-12-price-target

Wedbush analyst Robert Driscoll reiterates Omega Therapeutics (NASDAQ:OMGA) with a Outperform and maintains $12 price target.

 why-mobileye-global-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23...

 dow-surges-200-points-us-services-pmi-edges-higher-in-december

U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining around 200 points on Thursday. The D...

 famed-obesity-drug-maker-novo-nordisk-inks-collaborations-for-cardiometabolic-diseases

Novo Nordisk A/S (NYSE: NVO), Omega Therapeutics Inc (NASDAQ: OMGA), and Cellarity Inc.

 lamb-weston-posts-upbeat-results-joins-omega-therapeutics-allstate-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdin...

 us-stocks-mixed-jobless-claims-fall-to-202000

U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 50 points on Thursday. Following the market ope...

Core News & Articles

OMGA: 132% | Novo Nordisk Collaborates With Omega Therapeutics And Cellarity For Obesity, Metabolic Dysfunction-associated Stea...

Core News & Articles

First two research programmes signed under existing partnership between Novo Nordisk and Flagship Pioneering. Novo Nordisk w...

 hc-wainwright--co-maintains-buy-on-omega-therapeutics-raises-price-target-to-12

HC Wainwright & Co. analyst Robert Burns maintains Omega Therapeutics (NASDAQ:OMGA) with a Buy and raises the price targ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION